Finance

Beta
Lists
INAF:IDX
Indofarma Tbk PT
IDR 126.00
0.00%
(0.00) 1D
Jul 1, 2:55:02 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for INAF...
Mkt. cap
396.71B
Volume
0.00
52-wk high
IDR 126
52-wk low
IDR 126
EPS
-IDR 25
Shares outstanding
3.10B
No. of employees
44
Mkt. cap
396.71B
Volume
0.00
52-wk high
IDR 126
52-wk low
IDR 126
EPS
-IDR 25
Shares outstanding
3.10B
No. of employees
44
News stories
From sources across the web
About Indofarma Tbk PT
CEO-
Employees44
Founded1918
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
30.27B
66.71B
17.82B
53.33B
Cost of goods sold
35.60B
69.32B
22.60B
48.58B
Cost of revenue
35.60B
69.32B
22.60B
48.58B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.25B
69.13B
4.25B
6.91B
Operating expense
13.25B
76.01B
77.15B
7.93B
Total operating expenses
48.85B
145.32B
99.75B
56.50B
Operating income
-18.58B
-78.62B
-81.94B
-3.18B
Other non operating income
-
1.00
-1.00
-
EBT including unusual items
-18.85B
-74.21B
47.04B
-7.60B
EBT excluding unusual items
-18.85B
-74.21B
-111.28B
-7.60B
Income tax expense
-411.38M
9.33B
-2.06B
-21.03M
Effective tax rate
2.18%
-12.57%
-4.37%
0.28%
Other operating expenses
3.72M
6.87B
72.91B
1.02B
Net income
-18.44B
-83.54B
49.10B
-7.58B
Net profit margin
-60.93%
-125.23%
275.62%
-14.22%
Earnings per share
-
-
-
-
Interest and investment income
18.24M
29.68M
20.72M
-
Interest expense
-1.53B
-709.87M
-21.36B
-4.42B
Net interest expenses
-1.51B
-680.19M
-21.34B
-4.42B
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.38B
-75.41B
-78.45B
101.02M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more